X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1526) 1526
Newsletter (17) 17
Magazine Article (12) 12
Newspaper Article (12) 12
Book Chapter (10) 10
Conference Proceeding (5) 5
Transcript (2) 2
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
liraglutide (1258) 1258
science & technology (1201) 1201
life sciences & biomedicine (1178) 1178
humans (1117) 1117
diabetes mellitus, type 2 - drug therapy (810) 810
hypoglycemic agents - therapeutic use (729) 729
male (615) 615
type 2 diabetes (598) 598
glucagon-like peptide 1 - analogs & derivatives (561) 561
endocrinology & metabolism (536) 536
diabetes (515) 515
female (515) 515
liraglutide - therapeutic use (469) 469
glucagon-like peptide 1 - therapeutic use (433) 433
middle aged (414) 414
animals (341) 341
glucagon (303) 303
treatment outcome (297) 297
aged (274) 274
pharmacology & pharmacy (263) 263
adult (251) 251
insulin (248) 248
diabetes mellitus, type 2 - blood (239) 239
obesity (236) 236
glucose (232) 232
exenatide (231) 231
hypoglycemic agents - adverse effects (224) 224
hypoglycemic agents - pharmacology (217) 217
diabetes mellitus (216) 216
peptides - therapeutic use (215) 215
analysis (213) 213
drug therapy (206) 206
hypoglycemic agents - administration & dosage (205) 205
peptides (202) 202
blood glucose - drug effects (199) 199
venoms - therapeutic use (196) 196
care and treatment (183) 183
liraglutide - pharmacology (178) 178
blood glucose - metabolism (175) 175
clinical trials (170) 170
internal medicine (169) 169
glucagon-like peptide-1 receptor - agonists (168) 168
risk factors (166) 166
general & internal medicine (163) 163
diabetes therapy (161) 161
glucagon-like peptide-1 receptor (161) 161
diabetes mellitus, type 2 - complications (158) 158
medicine, general & internal (158) 158
glucagon-like peptide 1 - pharmacology (155) 155
obesity - drug therapy (155) 155
research (147) 147
body weight (142) 142
glp-1 (142) 142
glucagon-like peptide 1 (141) 141
drug therapy, combination (140) 140
glucagon-like peptide 1 - adverse effects (139) 139
abridged index medicus (136) 136
diabetes mellitus, type 2 - metabolism (136) 136
liraglutide - administration & dosage (136) 136
glycated hemoglobin a - metabolism (135) 135
glucagon-like peptide 1 - administration & dosage (130) 130
hypoglycemic agents (130) 130
receptors, glucagon - agonists (129) 129
mice (128) 128
medicine & public health (125) 125
weight loss - drug effects (125) 125
body mass index (124) 124
incretins - therapeutic use (123) 123
body weight - drug effects (120) 120
weight loss (120) 120
double-blind method (117) 117
health aspects (117) 117
dosage and administration (114) 114
type 2 diabetes mellitus (114) 114
dextrose (113) 113
insulin resistance (113) 113
diabetes mellitus, type 2 - physiopathology (111) 111
glycated hemoglobin a - analysis (109) 109
liraglutide - adverse effects (109) 109
metformin - therapeutic use (103) 103
glucagon-like peptide-1 (101) 101
rodents (101) 101
insulin - therapeutic use (98) 98
hypoglycemia (96) 96
patients (96) 96
dipeptidyl-peptidase iv inhibitors - therapeutic use (94) 94
medicine, research & experimental (94) 94
research & experimental medicine (94) 94
medical research (92) 92
rats (92) 92
endocrinology (91) 91
glycosylated hemoglobin (88) 88
randomized controlled trials as topic (88) 88
drug administration schedule (86) 86
weight control (86) 86
blood pressure (84) 84
metformin (81) 81
cardiovascular system & cardiology (80) 80
obesity - complications (80) 80
physiological aspects (79) 79
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1530) 1530
German (17) 17
Spanish (13) 13
Japanese (11) 11
French (7) 7
Czech (6) 6
Italian (6) 6
Chinese (4) 4
Danish (4) 4
Hungarian (2) 2
Croatian (1) 1
Dutch (1) 1
Polish (1) 1
Portuguese (1) 1
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 05/2017, Volume 152, Issue 7, pp. 1765 - 1779
Journal Article
Journal Article
Journal Article
Current medicinal chemistry, ISSN 0929-8673, 05/2017, Volume 25, Issue 13, pp. 1549 - 1566
It is known that Cardiovascular (CV) disease is the leading cause of morbidity and mortality in individuals with type 2 diabetes. Over the last years, one of... 
Cardiovascular events | Pioglitazone | Sulfonylureas | Dipeptidyl peptidase-4 inhibitors | Glucagon-like peptide-1 receptor agonists | Metformin | Insulin | Sodium-glucose co-transporters-2 inhibitors | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Metformin - therapeutic use | Cardiovascular Diseases - drug therapy | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Pioglitazone - therapeutic use | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Cardiovascular Diseases - complications | Glucagon-Like Peptides - pharmacology | Liraglutide - pharmacology | Glucosides - therapeutic use | Benzhydryl Compounds - therapeutic use | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Insulin - pharmacology | Glucosides - pharmacology | Sodium-Glucose Transporter 2 - metabolism | Metformin - pharmacology | Pioglitazone - pharmacology | Hypoglycemic Agents - pharmacology | Liraglutide - therapeutic use | Benzhydryl Compounds - pharmacology | Glucagon-Like Peptides - therapeutic use | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Insulin - therapeutic use | Heart | Diabetes mellitus | Clinical trials | Diabetes | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Patients | Morbidity
Journal Article